MarketPeel
Insider Trading Intelligence
Pricing
…
YH

Yujiro S. Hata

ENTA
DIRECTOR · ENANTA PHARMACEUTICALS INC · CIK 0001649119
FILING MIX · LIFETIME53%/47%
BUYS
30
SELLS
27
TOTAL VALUE
$19.93M
COMPANIES
3
ACTIVE SINCE
Jun 2016
HOLDINGS NOW
641,412
AVG SELL PX
$41.32
TRADE KIND
SHOWING 57 / 57
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Yujiro S. Hata, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+57.14%-0.80%+0.74%-1.55%-2.30%—
14d14+64.29%-5.13%+0.96%-6.09%-6.93%—
30d14+57.14%-0.83%+3.34%-4.17%-8.79%—
60d14+78.57%+0.70%+6.48%-5.78%-8.90%—
90d14+78.57%-4.84%+4.10%-8.94%-12.33%—
180d14+85.71%-15.37%+13.18%-28.54%-32.19%—
1y14+100.00%-50.68%+19.01%-69.68%-70.91%—
2y14+100.00%-25.43%+43.56%-68.98%-72.11%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ENTA · 20,000 shares · as of Mar 11, 2026
05,00010,00015,00020,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2016
2016
2016
2017
2017
2017
2017
2018
2018
2018
2018
2019
2019
2019
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 30 buys / 27 sellsCOVERAGE · 40 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
20,000——20,000Mar 11, 2026Mar 13, 2026 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
600,000——600,000Jan 30, 2026Feb 2, 2026 ↗View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,700——15,700Mar 13, 2025Mar 14, 2025 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
600,000——600,000Feb 27, 2025Feb 28, 2025 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
12,808——182,192Feb 18, 2025Feb 19, 2025 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
12,808$19.52$250.0K690,695Feb 18, 2025Feb 19, 2025 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
34,433——49,454May 16, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
34,433$4.31$148.4K712,320May 16, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
4,349$42.37$184.2K677,887May 16, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
30,084$41.73$1.26M682,236May 16, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
83,856——83,887May 15, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
29,761$43.48$1.29M678,390May 15, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
83,856$4.31$361.4K761,743May 15, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
503$44.12$22.2K677,887May 15, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
53,592$42.57$2.28M708,151May 15, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
54,408$41.60$2.26M680,190May 14, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
56,711$4.31$244.4K734,598May 14, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
2,303$41.84$96.3K677,887May 14, 2024May 16, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
56,711——167,743May 14, 2024May 16, 2024 ↗View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,700——15,700Mar 6, 2024Mar 8, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
480,000——480,000Mar 1, 2024Mar 4, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
23,557$45.54$1.07M677,887Feb 9, 2024Feb 12, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
23,557——224,454Feb 9, 2024Feb 12, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
23,557$4.31$101.5K701,444Feb 9, 2024Feb 12, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
75,815$45.15$3.42M677,887Feb 8, 2024Feb 12, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
75,815——248,011Feb 8, 2024Feb 12, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
75,815$4.31$326.8K753,702Feb 8, 2024Feb 12, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
628——323,826Feb 1, 2024Feb 5, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
4$45.01$180677,887Feb 1, 2024Feb 5, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
624$45.00$28.1K677,891Feb 1, 2024Feb 5, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
628$4.31$2.7K678,515Feb 1, 2024Feb 5, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
62,739$4.31$270.4K740,626Jan 16, 2024Jan 17, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
62,739——324,454Jan 16, 2024Jan 17, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
62,739$40.17$2.52M677,887Jan 16, 2024Jan 17, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
12,261$40.04$490.9K677,887Jan 12, 2024Jan 17, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
12,261——387,193Jan 12, 2024Jan 17, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
12,261$4.31$52.8K690,148Jan 12, 2024Jan 17, 2024 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
75,000$4.31$323.3K752,887Dec 15, 2023Dec 19, 2023 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE10b5-1
10b5-1 plan
75,000$35.03$2.63M677,887Dec 15, 2023Dec 19, 2023 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
75,000——399,454Dec 15, 2023Dec 19, 2023 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
11,601——474,454Apr 12, 2023Apr 13, 2023 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
11,601$4.31$50.0K677,887Apr 12, 2023Apr 13, 2023 ↗View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,800——10,800Mar 2, 2023Mar 6, 2023 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
400,000——400,000Feb 24, 2023Feb 28, 2023 ↗View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
21,412——21,412Jun 23, 2022Jun 27, 2022 ↗View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,500——7,500Mar 3, 2022Mar 7, 2022 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
260,000——260,000Mar 1, 2022Mar 3, 2022 ↗View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,144——13,144Aug 19, 2021Aug 23, 2021 ↗View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
9,728——9,728Jun 24, 2021Jun 25, 2021 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
195,000——195,000Feb 24, 2021Feb 26, 2021 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
8,000——486,055Dec 22, 2020Dec 23, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
8,000$4.31$34.5K666,286Dec 22, 2020Dec 23, 2020 ↗View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
13,953——13,953Jun 25, 2020Jun 26, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
SALE
President and CEO
47,564——494,055Apr 15, 2020Apr 16, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASE
President and CEO
47,564$4.31$205.0K658,286Apr 15, 2020Apr 16, 2020 ↗View →
IDYA
IDEAYA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
215,000——215,000Feb 21, 2020Feb 25, 2020 ↗View →
XNCR
XENCOR INC
PURCHASEGRANT
Stock grant
7,500——7,500Jun 23, 2016Mar 3, 2021 ↗View →
Other insiders · ENTA
Loading peer insiders…
About this filer
CIK 0001649119
ROLE
Director
PRIMARY
ENTA
COMPANIES
3
ACTIVE SINCE
Jun 2016
MARKETPEEL · /INSIDER/0001649119DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback